End-stage kidney disease
Conditions
Interventions
Sponsors
Sugiyama Daisuke
Jin Zhuan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who are scheduled for arteriovenous fistula creation for hemodialysis. 2. Patients who have a sufficient understanding of the research and provide consent. 3. Patients who are 18 years of age or older at the time of obtaining consent.
Exclusion criteria
Exclusion criteria: 1. Patients with arterial vessel diameter at the planned arteriovenous fistula site of 1.5mm or less. 2. Patients with venous vessel diameter at the planned arteriovenous fistula site of 2mm or less after tourniquet 3. Patients with significant arterial sclerosis at the planned arteriovenous fistula site. 4. Patients with glaucoma. 5. Patients with cataracts. 6. Patients with BMI >= 35. 7. Patients with skin disorders at the planned irradiation site. 8. Patients who are considered unsuitable for participation in this study by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference/percentage change in cephalic vein diameter before and after stellate ganglion light irradiation (mm/%) (with the use of tourniquet: 150mmHg; more than 10 seconds; measured using ultrasound) | — |
Secondary
| Measure | Time frame |
|---|---|
| (with the use of tourniquet: 150mmHg; more than 10 seconds; measured using ultrasound) 1. The difference/percentage change rate in vessel diameter before and after stellate ganglion light irradiation (mm/%): A) Radial artery B) Median artery C) Deep vein D)Brachial artery. 2. The pain VAS (Visual Analogue Scale) immediately after surgery. 3. Surgical duration. 4. The change of the planned fistula creation site from upper arm to forearm. 5. The fistula patency rate at 1 month: Confirmed by fistula sound, thrill, and ultrasound. | — |
Contacts
Public ContactZhuan Jin
Kameda Medical Center
Outcome results
None listed